CapitalRise secures £30 million institutional funding line
CapitalRise, the specialist lender for prime residential developers, has secured a £30 million institutional funding line from a major financial institution, further increasing the business’ lending capacity and offering within the specialist prime market.
This new facility enables continued acceleration of the company’s loan book growth and comes as the value of assets CapitalRise has lent against surpasses the £300 million milestone. CapitalRise’s new institutional partner will fund loans alongside the company’s existing funding sources and facilitate its ability to underwrite larger loans.
Uma Rajah, pictured, Co-Founder and CEO at CapitalRise, commented:
“This is another major milestone for CapitalRise and forms an integral part of the business’ growth plans. It provides us with more bandwidth to capitalise on the high volume of quality loan enquiries being generated by our origination team. To have attracted the attention of such a highly regarded institutional partner acts as a major validation of the quality of our lending.
“Having already invested in adding resource to meet our growing deal flow and expand marketing activities, this funding line and those we have in the pipeline are a strong endorsement of our strategy. They enable us to build on the foundations in place to scale the business across every metric, including our product range.”
Leveraging the agility associated with being a specialist alternative lender, CapitalRise benefits from its ability to respond quickly to borrowers’ funding needs. In turn, it means CapitalRise is able to deliver flexible and tailored financing solutions that match the specific requirements of each unique project. CapitalRise’s latest development loan, in London’s Belgravia, was funded in 33 days from enquiry to drawdown. Since its launch in 2016, CapitalRise has lent against over £300 million of prime property assets in locations such as Mayfair, Knightsbridge and the Home Counties and demand for finance in its specialist market remains robust.